Brazil Company Requests Emergency Authorization To Use India's Covaxin

Brazil Company Requests Emergency Authorization To Use India's Covaxin

March 9, 2021, 7:38 a.m.

SAO PAULO/ Brazilian company Precisa Medicamentos, representing India’s Bharat Biotech, on Monday said it requested that the country’s health regulator, Anvisa, grant emergency authorization to use the Covaxin COVID-19 vaccine.

In addition, it said Covaxin would be trialed in a Phase Three study in Brazil carried out in partnership with Sao Paulo’s Albert Einstein hospital.

More on Health

The Latest

Latest Magazine

VOL. 15, No. 08, Nov. 19, 2021 (Mangshir 03, 2078) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 15, No. 07, Oct. 29, 2021 (Kartik 12, 2078) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 15, No. 06, Oct. 08, 2021 (Ashoj 22, 2078) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 15, No. 05, Sep. 17, 2021 (Ashoj 01, 2078) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75